Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 12108

Bradenton, FL 34205

Study Summary:

This study is evaulating an investigational humanized monoclonal antibody to determine whether it may slow the progression of PPMS (Primary Progressive MS) The investigational drug drug is designed to target a type of white blood cells, called B-cells,that is believed to play a role in the progression of the disease. Researchers are increasingly studying the role B-cells may play in the nervous system damage that occurs in people with PPMS.

Qualified Participants Must:

• Be 18-55 years of age
• Have been diagnosed with Primary Progressive Multiple sclerosis

Qualified Participants May Receive:

Access to the investigational drug or placebo (inactive substance). Potential long-term access to the investigational drug during and extended treatment period(not all participants will be elgible for the study extension). Study related care and monitoring ( inclduing physical examinations, neurological exams, and MRI scans.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.